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Purpose: To characterize the clinical, psychophysical, and electrophysiological phenotypes in a five-generation Swiss
family with dominantly inherited retinitis pigmentosa caused by a T494M mutation in the Precursor mRNA-Processing
factor 3 (PRPF3) gene, and to relate the phenotype to the underlying genetic mutation.
Methods: Eleven affected patients were ascertained for phenotypic and genotypic characterization. Ophthalmologic
evaluations included color vision testing, Goldmann perimetry, and digital fundus photography. Some patients had
autofluorescence  imaging,  Optical  Coherence  Tomography,  and  ISCEV-standard  full-field  electroretinography.  All
affected patients had genetic testing.
Results: The age of onset of night blindness and the severity of the progression of the disease varied between members
of the family. Some patients reported early onset of night blindness at age three, with subsequent severe deterioration of
visual acuity, which was 0.4 in the best eye after their fifties. The second group of patients had a later onset of night
blindness,  in  the  mid-twenties,  with  a  milder  disease  progression  and  a  visual  acuity  of  0.8  at  age  70.  Fundus
autofluorescence imaging and electrophysiological and visual field abnormalities also showed some degree of varying
phenotypes. The autofluorescence imaging showed a large high-density ring bilaterally. Myopia (range: −0.75 to −8) was
found in 10/11 affected subjects. Fundus findings showed areas of atrophy along the arcades. A T494M change was found
in exon 11 of the PRPF3 gene. The change segregates with the disease in the family.
Conclusions: A mutation in the PRPF3 gene is rare compared to other genes causing autosomal dominant retinitis
pigmentosa (ADRP). Although a T494M change has been reported, the family in our study is the first with variable
expressivity. Mutations in the PRPF3 gene can cause a variable ADRP phenotype, unlike in the previously described
Danish, English, and Japanese families. Our report, based on one of the largest affected pedigree, provides a better
understanding as to the phenotype/genotype description of ADRP caused by a PRPF3 mutation.
Retinitis pigmentosa (RP) is a group of inherited retinal
degenerations  displaying  heterogeneity  in  age  of  onset,
disease  progression,  and  underlying  genetic  defect.  In
contrast, the later stages of the disease share common fundus
features  such  as  bone  spicule  pigmentation,  chorioretinal
atrophy, narrowed vessels, and optic disk pallor [1]. Typical
symptoms include night blindness, progressive visual field
constriction, and, eventually, legal blindness [2]. Retinitis
pigmentosa can result from mutations in more than 45 genes
[3]. Transmission is autosomal dominant (ADRP) in about
one  third  of  cases,  with  10%  of  these  cases  caused  by
mutations in one of three core pre-mRNA splicing factors:
Precursor  mRNA-Processing  factor  3  (PRPF3),  Precursor
mRNA-Processing factor 8 (PRPF8), and Precursor mRNA-
Processing factor 31 (PRPF31). All three genes are involved
in the assembly and function of the spliceosome, which clips
introns out of the pre-mRNA [4]. In the PRPF3 gene, two
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different  missense  mutations,  Thr494Met  and  Pro493Ser,
have been identified in patients with ADRP and simplex cases.
Both mutations are clustered within a two-codon stretch in
exon 11 and one of the mutations (T494M) is seen repeatedly
and has been identified in 1% of patients with ADRP in Japan
[5-7]
To date, the genotype/phenotype correlation of T494M in
PRPF3 is limited to a two-generation Japanese family, [7] a
seven-generation  Danish  family,  and  a  four-generation
English family, where only a brief description is available [8,
9]. Authors [7-9] describe a consistent phenotype: extremely
early onset of night blindness, severe visual field constriction,
loss of central vision between the fourth and fifth decade, and
a flat electroretinogram (ERG) after the age of 30.
In this report, we describe the phenotype of a large five-
generation Swiss family from Western Switzerland that is
affected with ADRP caused by a missense T494M mutation in
PRPF3.
METHODS
We  studied  11  affected  patients  and  11  asymptomatic
individuals from a family segregating ADRP originating from
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467Western Switzerland (Figure 1). The protocol of the study
adhered to the tenets of the Declaration of Helsinki and was
approved by the local Ethics Committee DFSP (035.0003–
48). After informed consent was obtained, blood samples
from affected and unaffected family members were taken on
EDTA  and  DNA  was  extracted  with  a  Nucleon2  kit  as
recommended  by  the  supplier  (GE  Healthcare,  Uppsala,
Sweden).
All patients had a full history and a complete ophthalmic
examination.  Medical  records  were  reviewed  when
accessible. Subjects underwent color fundus photography and
autofluorescence imaging (AF). Autofluorescence imaging
was obtained using a scanning laser ophthalmoscope (HRA2;
Heidelberg  Engineering,  Heidelberg,  Germany)  by
illuminating the fundus with an argon laser light (488 nm) and
viewing the resultant fluorescence through a band-pass filter
with a short wavelength cut off at 495 nm [10].
Pupils  were  dilated  using  tropicamide  1%  and
phenylephrine hydrochloride 2.5% before electrophysiology
testing. A full-field electroretinographe (ERG) was performed
using the International Society for Clinical Electrophysiology
of  Vision  (ISCEV)  standards  [11]  in  five  patients.  The
protocol included rod-specific and standard bright-flash ERG,
both recorded after a minimum of 20 min dark adaptation.
Following 10 min light adaptation, the photopic 30-Hz Flicker
cone and transient cone ERG were recorded [11].
Further tests were performed in some patients including
multifocal  ERG  (1  patient/11),  Goldmann  perimetry  (7
patients/11),  and  optical  coherence  tomography  (OCT;  4
patients/11). Color testing was performed using the Ishihara
pseudoisochromatic plates (5 patients/11).
The topographic distribution of autofluorescence across
the retina was measured using a gray scale-index of intensity
(0–255 units), along the vertical and horizontal meridians,
intersecting the foveal pixel [12], and scaled in degrees by
assuming a visual angle of 15° between the center of the optic
nerve and fovea.
The mutation 1482C>T (Thr494Met) in PRPF3 exon 11
was identified by microarray screening and confirmed by
bidirectional direct sequencing using Big Dye kit 1.1 after
amplification of exon 11 by polymerase chain reaction (PCR)
with the following primers: 5′-AAG TGA CTT CAA AGA
CTG ATT GTT G-3′ and 5′-CTC TTG ATC CAC ACT AGG
GTC A-3′.
RESULTS
Clinical evaluation: The clinical findings are summarized in
Table 1. In all patients, the first clinical symptom present was
night  blindness.  The  age  of  onset  varied  within  family
members from early childhood (2 to 7 years) in six cases and
to late teens (15 to 20 years) in four cases. One patient did not
complain of any night blindness. In family members reporting
early onset of night blindness, the disease progression was
more  severe  in  terms  of  visual  acuity.  In  those  patients
reporting  later  onset  of  night  blindness,  the  disease
progression was milder, retaining best corrected visual acuity
of 0.8 in the better eye until their late seventies. The two
younger patients of that group, 39 and 46 years old, both had
a best corrected visual acuity (BCVA) of 1.0 and 0.9. Within
patients reporting an early nigh blindness, the visual acuity in
the better eye was 0.4 in at 53 and 67 years old. In addition,
younger patients of that group had reduced vision: 0.4 and 0.3
at 27 years old and 0.6 bilaterally at 45 years old. Except the
young four-year-old girl V.3, all patients had myopia (range
−0.75 to −8 diopters) and astigmatism. Nystagmus was not
present in any patient.
Fundus appearance varied between patients according to
their age and the stage of disease. The youngest subject had
normal, although pale appearing fundus. The oldest patients
had  pale  discs,  narrowed  vessels,  and  extensive  retinal
Figure 1. Family tree. The proband is indicated with an arrow. All affected members are indicated by a black symbol.
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469epithelium pigment deposits outside and within the arcades.
Macular edema or foveal cyst-like changes were not observed
in any patient. In addition, OCT performed in four subjects
did not show any intraretinal cysts.
Peripheral visual field constriction with I/4e isopter, as
measured by Goldmann kinetic perimetry, varied from 5 to 30
degrees, with an average of 15.3°. In some cases, the testing
showed intrafamilial variability: patient III.3 had a visual field
of 9° and 10° (right eye and left eye respectively, isopter I4e)
when she was 67 years old, while her son IV.3, tested at age
45 years, had a visual field of 7° and 5° (isopter I/4e). A
longitudinal  data  of  Goldmann  visual  field  perimetry  of
subject III.9 over 7 years showed a mild progression from 10°
in both eyes when she was 64 years old to 7° and 5° at the last
visit.
Autofluorescence  imaging  showed  two  distinctive
patterns of abnormalities. In severely affected cases, there was
a decrease or lack of autofluorescence outside or within the
arcades (Figure 2A, Figure 3C). All patients who had AF
imaging  showed  a  ring  of  high  density  autofluorescence
(Figure  2A,C,E;  Figure  3A,C).  The  ring  of  increased  AF
varied between 4.4° and 26.2° of eccentricity from the fovea.
The inner radius of the AF ring in 10 eyes and the outer radius
in one patient (V.10) correlated with the Goldmann isopter I/
Figure 2. Autofluorescence and fundus
photography.  This  image  is  showing
progressive  constriction  of  perifoveal
ring of high density autofluorescence in
the grand-mother A (Proband III.9), her
daughter C (IV.9) and the grand son D
(V.11). A: An autofluorescence imaging
(AF) image of 70-year-old mother, right
eye.  Macula  with  a  small
hyperfluorescent ring. B: Color photo of
the same patient. Pale disc, bones spikes
at the periphery are shown. C: An AF
image of the right eye of her daughter,
46-year-old.  Macula  with  a  larger
hyperfluorescent ring. D: Color photo of
the same patient. Normal appearance is
shown. E: An AF image right eye (RE)
of 22-year-old grandson. Macula with a
larger hyperfluorescent ring. F: Color
photo  of  the  same  patient.  Normal
appearance is shown.
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4704e average radius (correlation coefficient r2: 0.81). In one
patient (V.11), the radius of AF ring correlated to a Goldmann
I/3e isopter radius.
Figure 2 shows a 70-year-old proband (Figure 2A,B), her
46-year-old  daughter  (Figure  2  C,D),  and  22-year-old
grandson (Figure 2E,F). The daughter’s ring of high density
AF was 12.4°and 12.6°, while the grandson’s was 15.4° in
both eyes.
Autofluorescence  imaging  of  the  four-year-old  girl
(Figure 3A) revealed large hyperfluorescent rings in both
maculas. She did not complain of any visual problems, but her
parents,  mostly  her  affected  father,  noticed  that  she  was
clumsy. A large hyperfluorescent ring on AF imaging was also
noticed in a 10-year-old girl who did not report any night
blindness (Figure 4C). This area did not correspond to any
fundoscopic abnormalities (Figure 4D). The Goldmann visual
field testing revealed constriction of isopter I/4e to 30° in both
eyes, as well as a dissociation of isopters I/4e and V/4e. Color
vision was severely reduced in one patient (III.9) and normal
in 3 (IV.3, IV.6, and V.10).
Functional  evaluation:  The  functional  findings  are
summarized in Table 2. All patients tested had undetectable
rod-specific  ERG.  The  photopic  ERG  showed  some
intrafamilial variability: a 43-year-old mother (IV.9), who had
a late onset of night blindness, had a less affected cone flicker
as compared to her 18-year-old son (V.11), with an early onset
of nyctalopia. The amplitude (in microvolts) of her photopic
30-Hz flicker ERG was within lower limit of normal (52.9),
versus 15.5 in her son. Patient IV.4, 27 at the time of his full
field ERG testing, was the most severely affected and had
undetectable rod and cone ERGs. His 39-year-old brother (IV.
3) was less affected; his photopic ERGs were still detectable,
although delayed and reduced.
Multifocal ERGs of patient III.9 showed a widespread
reduction with no preservation of the response associated with
the central stimulus element.
Mutation  detection:  Using  microarray  screening
(AsperOphthalmics, Tartu, Estonia), the proband (patient III.
9) was found to have a Thr494Met mutation in the PRPF3
gene. Presence of the c.1482C>T transition was confirmed
using direct bidirectional sequencing of exon 11 (Figure 5).
No previously reported mutation was detected in the CA4,
FSCN2,  IMPDH1,  NRL,  PRPF31,  PRPF8,  RDS,  RHO,
ROM1, RP1, RP9, CRX, TOPORS, and PNR genes.
The identified mutation co-segregated with the disease in
all affected family members tested (9 patients/11) and it was
not observed in 96 control individuals.
DISCUSSION
In this report we describe the phenotype-genotype correlation
in a five-generation Swiss family with a Thr494Met mutation
Figure 3. Autofluorescence and fundus
photography. This image is showing a
ring of high density autofluorescence of
a daughter, A (V.3) with normal fundus
and  her  father  C  (IV.3).  A:  An
autofluorescence  imaging  (AF)  image
of four-year-old girl, right eye. Macula
with a large hyperfluorescent ring. B:
Color photo of the same patient. Pale
appearance of fundus is shown. C: An
AF image of her 44-year-old father, left
eye.  Macula  with  a  small
hyperfluorescent ring. D: Color photo of
the same patient. Pale disc, narrowed
retinal  vessels,  bone  spikes  at  close
periphery are shown.
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471in PRPF3. This is one of the largest families described with
this mutation and is the first evidence for variable intrafamilial
expressivity.
Only two missense mutations have been described in
PRPF3, Thr494Met and Pro493Ser, as reported by Chakarova
[13]. Both codons 494 and 493, placed in the C-terminal
region of the protein, are highly conserved and this region has
been suggested to interact with other proteins [13,14]. The
T494M  mutation  is  considered  to  be  the  most  common
mutation,  as  it  has  been  reported  to  segregate  in  several
families from various ethnic background (English, Danish,
Spanish, Japanese, and North American), with a frequency of
1% among patients with ADRP.
The  previous  T494M-associated  phenotype  was
consistent and described an onset of night blindness in early
infancy,  a  visual  field  loss,  and  decreased  visual  acuity
between the ages of 30 and 40, as well as a flat ERG after the
age  of  30  [7-9].  Only  one  patient  carrying  a  mutation  in
PRPF3 has been examined in the Spanish family [5] and was
described as having a mild phenotype with first symptoms
(night blindness) at the age of 40.
Our Swiss family presented with variable expressivity in
regards to the age of onset of night blindness and disease
progression, as shown by a variable deterioration of central
visual acuity. The first group of patients reported nyctalopia
at  a  very  early  age,  with  subsequent  early  and  severe
deterioration of central vision. The BCVA of 0.4 was reported
after their fifties and was also measured in younger patients,
confirming a severe disease progression. The second group
reported night blindness in their late teens, early twenties, and
all patients from that group retained good visual acuity, even
after  the  age  of  70  (BCVA:  0.8).  Only  the  first  group’s
phenotype correlates with the phenotype of the other families
described [7-9]. All patients had some degree of myopia and
astigmatism, which has also been reported in some members
of the Danish family [9] and in one of the three patients
described in the Japanese family [7].
Goldmann  kinetic  perimetry  visual  field  testing  also
showed some degree of intrafamilial variability, as a younger
patient (IV.3) was more severely affected then his mother and
had the same degree of visual field constriction as a 71-year-
old  subject  (III.9)  from  that  family.  In  addition,  photopic
ERGs also showed some intrafamilial variability, as some
younger patients were more affected then older ones.
The autofluorescence imaging revealed a parafoveal ring
of high density autofluorescence in all tested patients. An
abnormal ring of hyperautofluorescence, which is not visible
on slit-lamp biomicroscopy, is frequently observed and has
been  reported  in  ADRP,  autosomal  recessive  retinitis
pigmentosa (arRP), and X-linked RP [15-17]. It has also been
Figure 4. Autofluorescence and fundus
photography. This image is showing a
ring  of  high  density  autofluorescence
imaging (AF) of a mother A (IV.6) and
her  asymptomatic  daughter  C  (V.10)
with normal fundus. A: An AF image of
39-year-old  mother,  left  eye.  Macula
with a hyperfluorescent ring. (B) Color
photo  of  the  same  patient.  Slight
narrowing of retinal arteries. C: An AF
image of her 10-year-old asymptomatic
daughter, left eye. Macula with a large
hyperfluorescent ring D: Color photo of
the same patient. Normal fundus.
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472documented  in  other  retinal  dystrophies,  including  Leber
congenital  amaurosis  [18],  cone-rod  dystrophy  [19],  Best
disease  [20],  and  X-linked  retinoschisis  [21].  The
hyperfluorescent  ring  might  be  due  to  early  cellular
dysfunction and the overproduction of lipofuscin [22]. It is a
non-specific  manifestation,  but  testing  by  pattern  and
multifocal  electroretinography,  OCT,  and  microperimetry
revealed that the retinal function inside the ring was more
preserved than outside the ring [10,15,16,23,24]. Our results
confirm  that  the  size  of  the  AF  ring  correlates  well  with
Goldmann perimetry, as has been previously reported [10,16,
24,25]. In our study, the average diameter of the AF ring
correlated with isopter I/4e, as opposed to isopter II/4e as
described in a previous study [24], or isopter V/4 in another
study [25]. This difference might be due to variability and a
suprathreshold  stimulus  of  kinetic  perimetry  described  in
patients with RP [26].
Autofluorescence is useful to confirm a retinal dystrophy
and to monitor its progression. In this family, a 10-year-old
girl claimed to be asymptomatic and her clinical examination
was unremarkable (Figure 4D). The diagnosis of the disease
was only suspected based on family history and visual field,
TABLE 2. QUANTITATIVE ERG RESULTS, AVERAGE OF BOTH EYES. AMPLITUDES AND IMPLICIT TIMES OF ROD SPECIFIC, MAXIMAL MIXED ROD-CONE RESPONSES (MAX),
PHOTOPIC 30-HZ FLICKER, AND TRANSIENT PHOTOPIC TRACINGS ARE SHOWN.
Amplitude (microvolts [mV]) Implicit time (ms)
Electroretinogram a-wave b-wave a-wave b-wave
Rod specific
Patient 2 IV.3 (39 years)   NR   NR
Patient 3 IV.4 (27 years)   NR   NR
Patient 6 IV.6 (28 years)   NR   NR
Patient 9 IV.9 (46 years)   NR   NR
Patient 10 V.11 (18 years)   NR   NR
Max ERG
Patient 2 (IV.3) 36.5 (167.2*) 69.7 (349.2*) 32.5 (24.3*) 54 (53.5*)
Patient 3 (IV.4) NR NR NR NR
Patient 6 (IV.6) 43.1 (188.2*) 22 (365.2*) 30.9 (24*) 38 (53.5*)
Patient 9 (IV.9) 90.6 (156.8*) 49.1 (341.2*) 27.5 (24.5*) 52.8 (53.5*)
Patient 10 (V.11) 21.1 (210.3*) 41.5 (382.0*) 20.3 (23.7*) 58 (53.5*)
Photopic 30-Hz flicker
Patient 2 (IV.3)   8.6 (46.4*)   45.3 (31.6*)
Patient 3 (IV.4)   NR   NR
Patient 6 (IV.6)   20.4 (53.4*)   42.9 (31.3*)
Patient 9 (IV.9)   52.9 (42.9*)   41.4 (31.3*)
Patient 10 (V.11)   15.5 (60.8*)   42.4 (31.3*)
Transient photopic
Patient 2 (IV.3) 19.5 38.1 (71*) 19.3 78.3 (32*)
Patient 3 (IV.4) NR NR NR NR
Patient 6 (IV.6) 8.1 16.4 (81.9*) 22.5 47.0 (32.5*)
Patient 9 (IV.9) 40.4 108.9 (66*) 20.8 39 (32.5*)
Patient 10 (V.11) 13.9 36.4 (91.5*) 18.3 44 (32.5*)
Asterisk (*) indicates the lower threshold of normal amplitude (age-adjusted) or implicit time, defined as two standard deviations
below the mean of normal controls. NR represents non recordable.
Figure 5. Electropherogram. This image is showing mutation 1482 C>T (Thr494Met) in Precursor mRNA-Processing factor 3 (PRPF3). The
arrow showing the “double hill” at position 73, corresponding to heterozygote mutation.
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473and  was  confirmed  with  AF  imaging:  she  had  bilateral
parafoveal large rings of high density AF (Figure 4C) [27]. It
might often be challenging to obtain reliable ERG results in
small children with retinal dystrophies, partly because the
normative values of healthy children are not easily available
in  most  diagnostic  centers.  Our  study  suggests  that  AF
imaging can be a more child-friendly tool in diagnosing RP
in young or asymptomatic children.
In  summary,  our  report  describes  a  spectrum  of
phenotypes of ADRP due to a PRPF3 T494M mutation in a
large  five-generation  family,  in  which  we  examined  11
affected members. Our series also highlights the importance
of using AF in evaluating young children and in monitoring
adult patients.
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